Canadian Securities Regulators advises issuers and users of recent changes to the availability of public regulatory filings on  Public regulatory filings are now accessible on within fifteen minutes of the original submission through the SEDAR filing system.  New reporting issuer profiles that are made public, as well as updates to existing profiles, will also appear on within 15 minutes of the original submission.

Bradmer Pharmaceuticals Inc.
Mailing Address: 365 Bay Street
Suite 800
Toronto, Ontario
M5H 2V1
Head Office Address: 365 Bay Street
Suite 800
Toronto, Ontario
M5H 2V1
Contact Name: Paul Van Damme, Chief Financial Officer Principal Regulator: Ontario
Business e-mail address: Short Form Prospectus Issuer: Yes
Telephone Number: 416 847-6905 Reporting Jurisdictions: British Columbia, Alberta, Manitoba, Ontario, Quebec
Fax Number: 416 946-1008 Stock Exchange: NEX
Date of Formation: Feb 10 2006 Stock Symbol: BMR
Jurisdiction Where Formed: Ontario Auditor: Collins Barrow Toronto LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 10463R Transfer Agent: Equity Financial Trust Company
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000

View This Public Company's Documents